Arrhythmogenic Cardiomyopathy
The research project, named IMPACT - Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic card…
The research project, named IMPACT - Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic card…
The Gerresheimer subsidiary in Peachtree City, USA, was named an approved “Contract Manufacturer for VERO Biotech’s GENO…
The EXCOR® Graft Cannula* connects the outflow side of the blood pump to the ascending aorta for left ventricular suppor…
Die neue EXCOR® Graftkanüle* verbindet die Auslassseite der Blutpumpe mit der aufsteigenden Aorta für die linksventrikul…
EBAMed SA, an early-stage medical device company pioneering new approaches to proton therapy today announced the enrollm…
First-ever data on therapeutic miR-132 inhibition in a large animal model of nonischemic heart failure with cardiac hype…
This observational, international, multi-center study investigates the improved mobility, patient outcome and the impact…
Diese internationale, multizentrische Beobachtungsstudie untersucht die verbesserte Mobilität und die Auswirkungen des m…
These patients are in a life-threatening condition: their health has deteriorated so much that they desperately need a n…
Diese Patienten befinden sich in einem lebensbedrohlichen Zustand: Ihr Gesundheitszustand hat sich so stark verschlechte…